Fortfahren mit
Größe auswählen
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 200 mg | Warenkorb auf Verfügbarkeit prüfen | € 407,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
API family
oxytetracycline
form
solid
manufacturer/tradename
USP
application(s)
USP Biologics
pharmaceutical (small molecule)
format
neat
SMILES string
O.[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)c4c(O)cccc4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C
InChI
1S/C22H24N2O9.H2O/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29;/h4-6,12-14,17,25,27-29,32-33H,1-3H3,(H2,23,31);1H2/t12-,13-,14+,17+,21-,22+;/m1./s1
InChI key
IBZHEBHGZFICKS-IFLJXUKPSA-N
General description
Oxytetracycline is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. It is effective against a range of Gram-positive and Gram-negative organisms. The USP reference standard ensures assay precision and identity confirmation in oxytetracycline drug products.
The USP biologics antibiotics category includes a wide range of antimicrobial agents that are essential in treating bacterial infections. These antibiotics are derived from various natural sources or synthesized to combat specific pathogens effectively. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of antibiotic therapeutics throughout their lifecycle.
The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.
Application
- Oxytetracycline Hydrochloride
- Oxytetracycline Injection
- Oxytetracycline Tablets
- Oxytetracycline for Injection
- Oxytetracycline Hydrochloride Capsules
- Oxytetracycline Hydrochloride Soluble Powder
Biochem/physiol Actions
Mode of Action: Inhibits protein synthesis (elongation) by preventing binding of aminoacyl-tRNA to the 30S subunit.
Antimicrobial spectrum: Gram-negative and Gram-positive bacteria.
Mode of Resistance: Active efflux, ribosome protection, tetracycline inactivation.
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard | grade - |
| manufacturer/tradename USP | manufacturer/tradename BP | manufacturer/tradename - | manufacturer/tradename - |
| form solid | form solid | form - | form powder |
| format neat | format neat | format neat | format - |
| application(s) USP Biologics | application(s) pharmaceutical | application(s) pharmaceutical (small molecule) | application(s) environmental |
| API family oxytetracycline | API family oxytetracycline | API family oxytetracycline | API family - |
Still not finding the right product?
Explore all of our products under Oxytetracyclin
signalword
Warning
hcodes
Hazard Classifications
Aquatic Chronic 2 - Repr. 2
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 1491004-200MG | 04061838738172 |



